Abstract
A metabolic pathway is a series of biological processes providing necessary molecules and energies for an organism, which could be essential to the lives of the living organisms. Most metabolic pathways require the involvement of compounds and given a compound it is helpful to know what types of metabolic pathways the compound participates in. In this study, compounds are first represented by molecular fragments which are then delivered to a prediction engine called Sequential Minimal Optimization (SMO) for predictions. Maximum relevance and minimum redundancy (mRMR) and incremental feature selection are adopted to extract key features based on which an optimal prediction engine is established. The proposed method is effective comparing to the random forest, Dagging and a popular method that integrating chemical-chemical interactions and chemical-chemical similarities. We also make predictions using some compounds with unknown metabolic pathways and choose 17 compounds for analysis. The results indicate that the method proposed may become a useful tool in predicting and analyzing metabolic pathways.
Keywords: Compound, metabolic pathway, molecular fragment, minimum redundancy maximum relevance, incremental feature selection, sequential minimal optimization.
Combinatorial Chemistry & High Throughput Screening
Title:Predicting the types of metabolic pathway of compounds using molecular fragments and sequential minimal optimization
Volume: 19 Issue: 2
Author(s): Lei Chen, Chen Chu and Kaiyan Feng
Affiliation:
Keywords: Compound, metabolic pathway, molecular fragment, minimum redundancy maximum relevance, incremental feature selection, sequential minimal optimization.
Abstract: A metabolic pathway is a series of biological processes providing necessary molecules and energies for an organism, which could be essential to the lives of the living organisms. Most metabolic pathways require the involvement of compounds and given a compound it is helpful to know what types of metabolic pathways the compound participates in. In this study, compounds are first represented by molecular fragments which are then delivered to a prediction engine called Sequential Minimal Optimization (SMO) for predictions. Maximum relevance and minimum redundancy (mRMR) and incremental feature selection are adopted to extract key features based on which an optimal prediction engine is established. The proposed method is effective comparing to the random forest, Dagging and a popular method that integrating chemical-chemical interactions and chemical-chemical similarities. We also make predictions using some compounds with unknown metabolic pathways and choose 17 compounds for analysis. The results indicate that the method proposed may become a useful tool in predicting and analyzing metabolic pathways.
Export Options
About this article
Cite this article as:
Chen Lei, Chu Chen and Feng Kaiyan, Predicting the types of metabolic pathway of compounds using molecular fragments and sequential minimal optimization, Combinatorial Chemistry & High Throughput Screening 2016; 19 (2) . https://dx.doi.org/10.2174/1386207319666151110122453
DOI https://dx.doi.org/10.2174/1386207319666151110122453 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Revolutionary Impact of Nanodrug Delivery on Neuroscience
Current Neuropharmacology Application of Resveratrol in Diabetes: Rationale, Strategies and Challenges
Current Molecular Medicine Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine <i>Drosophila melanogaster</i> a Versatile Model of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Dioxin Decomposition and Detection Using Gold Based Materials
Recent Patents on Chemical Engineering Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol
Current Drug Metabolism A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Proteomic Strategies for the Analysis of Carbonyl Groups on Proteins
Current Protein & Peptide Science Hsp70 Protein Complexes as Drug Targets
Current Pharmaceutical Design Nanostructures as Promising Tools for Delivery of Antimicrobial Peptides
Mini-Reviews in Medicinal Chemistry Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Current Pharmacogenomics Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Drug Discovery: Methods for Identifying New Drug Targets
Drug Design Reviews - Online (Discontinued) In situ Generation of Efficient Palladium N-heterocyclic Carbene Catalysts Using Benzimidazolium Salts for the Suzuki-Miyaura Cross-coupling Reaction
Current Organic Synthesis Aqueous Extract of Argania spinosa L. Fruits Ameliorates Diabetes in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Extracellular Vesicles in the Treatment of Parkinson’s Disease: A Review
Current Medicinal Chemistry NAMPT in Regulated NAD Biosynthesis and its Pivotal Role in Human Metabolism
Current Medicinal Chemistry Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents
Anti-Cancer Agents in Medicinal Chemistry Chiral Separation of Several Flavanones by Liquid Chromatography
Current Pharmaceutical Analysis